Patents Assigned to Akesis Pharmaceuticals, Inc.
  • Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
    Publication number: 20060252686
    Abstract: Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
    Type: Application
    Filed: March 22, 2006
    Publication date: November 9, 2006
    Applicant: Akesis Pharmaceuticals, Inc.
    Inventors: Stuart Fine, Kevin Kinsella
  • Compositions and methods for treatment for glucose metabolism disorders
    Patent number: 6852760
    Abstract: Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
    Type: Grant
    Filed: September 17, 1999
    Date of Patent: February 8, 2005
    Assignee: Akesis Pharmaceuticals, Inc.
    Inventors: Stuart A. Fine, Kevin J. Kinsella
  • Metforimin-containing compositions for the treatment of diabetes
    Patent number: 6376549
    Abstract: Compositions and methods using same for the treatment of diabetes its sequelae and pre-diabetic conditions are provided. Invention compositions include the anti-diabetic agent metformin, and bioavailable sources of one or more of chromium, vanadium and magnesium. Also provided are pharmaceutical agents containing invention compositions and methods for administering such agents.
    Type: Grant
    Filed: September 17, 1998
    Date of Patent: April 23, 2002
    Assignee: Akesis Pharmaceuticals, Inc.
    Inventors: Stuart A. Fine, Kevin J. Kinsella
  • Dietary supplement and method of treatment for diabetic control
    Patent number: 6203819
    Abstract: A daily nutritional supplement and method of administering it to assist in the metabolism of glucose for patients with diabetes and pre-diabetes is disclosed. The supplement preferably includes anchor components of Chromium Polynicotinate and Picolinate, Vanadyl Sulfate, Vitamin E Natural, Standardized Willow Bark (aspirin), and Magnesium Chloride, Citrate, Fumarate, Malate, Glutorate, and Succinate Complex, Folic Acid, and Alpha-Lipoic Acid.
    Type: Grant
    Filed: March 19, 1999
    Date of Patent: March 20, 2001
    Assignee: Akesis Pharmaceuticals, Inc.
    Inventor: Stuart A. Fine
  • Dietary supplement and method of treatment for diabetic control
    Patent number: 5962030
    Abstract: A daily nutritional supplement and method of administering it to assist in the metabolism of glucose for patients with diabetes and pre-diabetes is disclosed. The supplement preferably includes anchor components of Chromium Polynicotinate and Picolinate, Vanadyl Sulfate, Vitamin E Natural, Standardized Willow Bark (aspirin), and Magnesium Chloride, Citrate, Fumarate, Malate, Glutorate, and Succinate Complex, Folic Acid, and Alpha-Lipoic Acid.
    Type: Grant
    Filed: November 5, 1997
    Date of Patent: October 5, 1999
    Assignee: Akesis Pharmaceuticals, Inc.
    Inventor: Stuart A. Fine